Education
About Us
Working with TipRanks
Follow Us
Revelation Biosciences Inc. (REVB)
:REVB
REVB Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.74 - $60.80
Previous CloseN/A
Volume326.26K
Average Volume (3M)1.99M
Market Cap
$1.51M
Enterprise Value$1.42B
Total Cash (Recent Filing)$3.70M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.35
Next Earnings
Aug 08, 2025EPS Estimate
-5.97Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.11
Shares Outstanding2,029,796
10 Day Avg. Volume375,962
30 Day Avg. Volume1,989,672
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)-390.52K
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap938.23
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-41.65
Forecast
1Y Price Target
$20.00Price Target Upside2566.67% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Revelation Biosciences News
PremiumCompany Announcements
Revelation Biosciences Raises $4M in Public OfferingPremiumCompany Announcements
Revelation Biosciences Board Member Resigns Amid New Role
Options Prices
Currently, No data available
---
Ownership Overview
2.28% Insiders
0.04% Mutual Funds
0.51% Other Institutional Investors
97.68% Public Companies and Individual Investors
REVB FAQ
What was Revelation Biosciences Inc.’s price range in the past 12 months?
Revelation Biosciences Inc. lowest stock price was $0.74 and its highest was $60.80 in the past 12 months.
What is Revelation Biosciences Inc.’s market cap?
Revelation Biosciences Inc.’s market cap is $1.51M.
When is Revelation Biosciences Inc.’s upcoming earnings report date?
Revelation Biosciences Inc.’s upcoming earnings report date is Aug 08, 2025 which is in 47 days.
How were Revelation Biosciences Inc.’s earnings last quarter?
Revelation Biosciences Inc. released its earnings results on May 08, 2025. The company reported -$2.11 earnings per share for the quarter, beating the consensus estimate of -$6.88 by $4.77.
Is Revelation Biosciences Inc. overvalued?
According to Wall Street analysts Revelation Biosciences Inc.’s price is currently Undervalued.
Does Revelation Biosciences Inc. pay dividends?
Revelation Biosciences Inc. does not currently pay dividends.
What is Revelation Biosciences Inc.’s EPS estimate?
Revelation Biosciences Inc.’s EPS estimate is -5.97.
How many shares outstanding does Revelation Biosciences Inc. have?
Revelation Biosciences Inc. has 2,029,796 shares outstanding.
What happened to Revelation Biosciences Inc.’s price movement after its last earnings report?
Revelation Biosciences Inc. reported an EPS of -$2.11 in its last earnings report, beating expectations of -$6.88. Following the earnings report the stock price went up 2.581%.
Which hedge fund is a major shareholder of Revelation Biosciences Inc.?
Currently, no hedge funds are holding shares in REVB
Company Description
Revelation Biosciences Inc.
Revelation Biosciences (REVB) is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the treatment of respiratory and other diseases. The company's core products include therapeutic candidates designed to modulate the immune system to improve health outcomes. Revelation Biosciences operates within the biotechnology sector, leveraging scientific research to address unmet medical needs.